Recursion Pharmaceuticals (RXRX) Short Interest Ratio & Short Volume → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free RXRX Stock Alerts $7.94 +0.24 (+3.12%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Recursion Pharmaceuticals Short Interest DataCurrent Short Volume39,760,000 sharesPrevious Short Volume43,520,000 sharesChange Vs. Previous Month-8.64%Dollar Volume Sold Short$396.41 millionShort Interest Ratio / Days to Cover5.7Last Record DateMarch 31, 2024Outstanding Shares234,650,000 sharesFloat Size146,570,000 sharesShort Percent of Float27.13%Today's Trading Volume7,198,081 sharesAverage Trading Volume4,079,786 sharesToday's Volume Vs. Average176% Short Selling Recursion Pharmaceuticals ? Sign up to receive the latest short interest report for Recursion Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRXRX Short Interest Over TimeRXRX Days to Cover Over TimeRXRX Percentage of Float Shorted Over Time Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report Recursion Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202439,760,000 shares $396.41 million -8.6%27.1%5.7 $9.97 3/15/202443,520,000 shares $488.29 million +1.6%29.7%6.2 $11.22 2/29/202442,820,000 shares $576.36 million +12.0%29.2%6.4 $13.46 2/15/202438,240,000 shares $475.32 million -0.1%26.1%6 $12.43 1/31/202438,270,000 shares $360.12 million +0.5%25.2%7.1 $9.41 1/15/202438,090,000 shares $425.08 million +2.8%25.1%7.3 $11.16 Get the Latest News and Ratings for RXRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Recursion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/202337,040,000 shares $365.21 million +0.1%24.4%8.1 $9.86 12/15/202337,020,000 shares $359.09 million +3.1%24.4%9.2 $9.70 11/30/202335,920,000 shares $246.05 million +1.2%23.9%9.1 $6.85 11/15/202335,500,000 shares $254.89 million +7.4%23.6%9.6 $7.18 10/31/202333,050,000 shares $174.50 million +3.8%23.9%9.3 $5.28 10/15/202331,850,000 shares $203.20 million +3.6%23.0%8.5 $6.38 9/30/202330,750,000 shares $235.24 million +26.3%22.2%4.6 $7.65 9/15/202324,340,000 shares $208.59 million +5.6%17.7%3.8 $8.57 8/31/202323,040,000 shares $200.45 million +11.8%17.6%3.8 $8.70 8/15/202320,610,000 shares $189.41 million +4.8%15.8%3.3 $9.19 7/31/202319,670,000 shares $277.74 million -0.3%16.6%3.4 $14.12 7/15/202319,720,000 shares $234.67 million +6.4%16.7%3.8 $11.90 6/30/202318,540,000 shares $138.49 million -5.0%15.7%8.9 $7.47 6/15/202319,520,000 shares $181.54 million +5.7%16.5%9.7 $9.30 5/31/202318,460,000 shares $161.89 million -7.7%15.8%9.9 $8.77 5/15/202320,000,000 shares $112 million -2.2%17.3%12.4 $5.60 4/30/202320,440,000 shares $97.50 million +2.2%17.8%18.4 $4.77 4/15/202320,000,000 shares $118.80 million +0.9%17.4%19.6 $5.94 3/31/202319,830,000 shares $132.27 million +4.3%17.3%20.3 $6.67 3/15/202319,020,000 shares $142.27 million +8.1%16.6%19 $7.48 2/28/202317,600,000 shares $143.44 million +1.7%15.4%16.4 $8.15 2/15/202317,310,000 shares $146.10 million -3.1%15.2%15.3 $8.44 1/31/202317,870,000 shares $148.86 million +2.2%16.7%14.4 $8.33 1/15/202317,480,000 shares $152.08 million +4.2%15.1%14 $8.70 12/30/202216,780,000 shares $129.37 million +17.8%14.4%13.9 $7.71 12/15/202214,240,000 shares $120.61 million -4.4%12.2%11.9 $8.47 11/30/202214,890,000 shares $139.97 million -0.2%13.5%11.9 $9.40 11/15/202214,920,000 shares $176.95 million -5.6%13.6%12.8 $11.86 10/31/202215,800,000 shares $166.69 million +1.6%19.3%14.1 $10.55 10/15/202215,550,000 shares $163.12 million -3.9%18.4%14.4 $10.49 9/30/202216,180,000 shares $172.16 million +12.4%19.2%14.8 $10.64 9/15/202214,390,000 shares $188.65 million -1.4%17.1%12.2 $13.11 8/31/202214,590,000 shares $153.34 million -7.6%17.4%14.3 $10.51 8/15/202215,790,000 shares $204.64 million -5.8%18.9%15.6 $12.96Biden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report RXRX Short Interest - Frequently Asked Questions What is Recursion Pharmaceuticals' current short interest? Short interest is the volume of Recursion Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 39,760,000 shares of RXRX short. 27.13% of Recursion Pharmaceuticals' shares are currently sold short. Learn More on Recursion Pharmaceuticals' current short interest. What is a good short interest ratio for Recursion Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RXRX shares currently have a short interest ratio of 6.0. Learn More on Recursion Pharmaceuticals's short interest ratio. What is a good short interest percentage for Recursion Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 27.13% of Recursion Pharmaceuticals' floating shares are currently sold short. Is Recursion Pharmaceuticals' short interest increasing or decreasing? Recursion Pharmaceuticals saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 39,760,000 shares, a decrease of 8.6% from the previous total of 43,520,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Recursion Pharmaceuticals' float size? Recursion Pharmaceuticals currently has issued a total of 234,650,000 shares. Some of Recursion Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Recursion Pharmaceuticals currently has a public float of 146,570,000 shares. How does Recursion Pharmaceuticals' short interest compare to its competitors? 27.13% of Recursion Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies compare to Recursion Pharmaceuticals: Fusion Pharmaceuticals Inc. (6.13%), Schrödinger, Inc. (8.63%), Twist Bioscience Co. (21.20%), Sana Biotechnology, Inc. (22.16%), Ginkgo Bioworks Holdings, Inc. (20.21%), Beam Therapeutics Inc. (16.34%), PTC Therapeutics, Inc. (13.39%), Neumora Therapeutics, Inc. (10.10%), Inhibrx, Inc. (6.04%), ADMA Biologics, Inc. (3.19%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Recursion Pharmaceuticals stock? Short selling RXRX is an investing strategy that aims to generate trading profit from Recursion Pharmaceuticals as its price is falling. RXRX shares are trading up $0.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Recursion Pharmaceuticals? A short squeeze for Recursion Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RXRX, which in turn drives the price of the stock up even further. How often is Recursion Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RXRX, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: FUSN Short Interest SDGR Short Interest TWST Short Interest SANA Short Interest DNA Short Interest BEAM Short Interest PTCT Short Interest NMRA Short Interest INBX Short Interest ADMA Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RXRX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative1970’s computer coder issues shocking A.I. warningTradeSmith